Guangzhou Pharmaceutical Holdings signed the letter of intent with Bio Cuba Farma, the largest state-owned pharmaceutical enterprise in Cuba on November 3, and both parties will jointly research and develop, produce and sell innovative pharmaceutical products including biological drugs in China, and strengthen exchanges in medical biotechnology and talent.
According to introduction, the cooperation of both parties covers R&D, production and sales of bio-pharmaceutical products as well as construction of R&D platform for bio-medical technology, including the introduction of several innovative biological drugs and imitation biological drugs of high technical content, etc. to Chinese market.
Bio Cuba Farma is the largest state-owned pharmaceutical enterprise in Cuba, and possesses 38 enterprises, including biotechnology company and pharmaceutical company, as shown in the public data. The group is very distinctive in vaccine and monoclonal antibody pharmaceutical product; and Guangzhou Pharmaceutical Holdings has certain advantages in pharmaceutical product manufacturing capability and pharmaceutical circulation network.
